Kana Daijo

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Akira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa et al. · Hepatology Communications · 2019 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Yuko Nagaoki, Michio Imamura, Hiroshi Aikata et al. · PLoS ONE · 2017 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring

Fumi Honda, Akira Hiramatsu, Hideyuki Hyogo et al. · PLoS ONE · 2018 · 49 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy

Yuko Nagaoki, Michio Imamura, Yuno Nishida et al. · Journal of Medical Virology · 2018 · 36 citations

Pharmacy, Oncology, Pharmacology +17

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury

Kei Morio, Michio Imamura, Kana Daijo et al. · Journal of Gastroenterology · 2017 · 31 citations

Medicine, Immunology, Pathology +15